Ichiro Horie

15PUBLICATIONS
43CO-AUTHORS
Major global burdens of diseasePredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Traditional Chinese medicine and treatmentsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Nov 26, 2025
Impacts of physical, metabolic, and immunological factors on the exophthalmometry values of a contemporary Japanese population with/without Graves' disease.

Erika Nakaji, Yuta Nakamura, Ichiro Horie

|Sep 15, 2025
Slowly progressive type 1 diabetes and female sex as associated factors for pancreatic abnormalities on diagnostic imaging indicating precancerous potential.

Tomoyasu Fukui, Tetsuro Kobayashi, Takuya Awata

|Sep 03, 2025
Real-world clinical experience of reduced-dose initiation of lenvatinib in Japanese patients with radioiodine-refractory differentiated thyroid cancer.

Yomi Nakashima, Ichiro Horie, Haruka Arimori

|Jun 26, 2025
Adjunct Therapy with Ipragliflozin Exerts Limited Effects on Kidney Protection in Type 1 Diabetes: A Retrospective Study Conducted at 25 Centers in Japan (IPRA-CKD).

Yuta Nakamura, Ichiro Horie, Hiroshi Yano

|Aug 17, 2024
A Randomized Controlled Trial on the Effect of Luseogliflozin on Bone Microarchitecture Evaluated Using HR-pQCT in Elderly Type 2 Diabetes.

Riyoko Shigeno, Ichiro Horie, Ai Haraguchi

|Aug 05, 2024
Advances in clinical research on glucagon.

Ichiro Horie, Norio Abiru

Pageof 3

Frequent Collaborators

3 joint publications

Yuta Nakamura

2 joint publications

Junji Kozawa

2 joint publications

Ai Haraguchi

2 joint publications

Yoshiki Kusunoki